The Consensus EPS Estimates For LENZ Therapeutics, Inc. (NASDAQ:LENZ) Just Fell Dramatically [Yahoo! Finance]
LENZ Therapeutics, Inc. (LENZ)
Company Research
Source: Yahoo! Finance
NASDAQ:LENZ ) shareholders today, when the analysts downgraded their forecasts for this year. Revenue and earnings per share (EPS) forecasts were both revised downwards, with the analysts seeing grey clouds on the horizon. Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. After this downgrade, LENZ Therapeutics' seven analysts are now forecasting revenues of US$28m in 2026. This would be a major 48% improvement in sales compared to the last 12 months. Losses are supposed to balloon 43% to US$3.75 per share. Yet before this consensus update, the analysts had been forecasting revenues of US$50m and losses of US$2.93 per share in 2026. Ergo, there's been a clear change in sentiment, with the analysts administering a notable cut to this year's revenue estimates, while at the same time increasing their loss per share forecasts. Check out our latest analysis for LENZ Therapeutics NasdaqGS:LENZ Earnings and Revenu
Show less
Read more
Impact Snapshot
Event Time:
LENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LENZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LENZ alerts
High impacting LENZ Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
LENZ
News
- LENZ Therapeutics: Speculative But Strong Buy [Seeking Alpha]Seeking Alpha
- Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week [Yahoo! Finance]Yahoo! Finance
- LENZ Therapeutics: Q4 Results Highlight A Worrying Lack Of Market Demand (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- LENZ Therapeutics (LENZ) had its price target lowered by Citigroup Inc. from $52.00 to $26.00. They now have a "buy" rating on the stock.MarketBeat
- LENZ Therapeutics (LENZ) had its price target lowered by Bank of America Corporation from $35.00 to $29.00. They now have a "buy" rating on the stock.MarketBeat
LENZ
Earnings
- 3/24/26 - Miss
LENZ
Sec Filings
- 4/8/26 - Form SCHEDULE
- 3/30/26 - Form 4
- 3/30/26 - Form 4
- LENZ's page on the SEC website